A biologically informed, interpretable deep learning model has been developed to evaluate molecular drivers of resistance to cancer treatment, predict clinical outcomes and guide hypotheses on disease progression.
- Haitham A. Elmarakeby
- Justin Hwang
- Eliezer M. Van Allen